Terms: = Germ cell tumor AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
3222 results:
1. A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.
Hussein R; Abou-Shanab AM; Badr E
NPJ Syst Biol Appl; 2024 May; 10(1):52. PubMed ID: 38760476
[TBL] [Abstract] [Full Text] [Related]
2. KAP1 stabilizes mycn mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m
Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y
J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192
[TBL] [Abstract] [Full Text] [Related]
3. Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy.
Halpert MM; Burns BA; Rosario SR; Withers HG; Trivedi AJ; Hofferek CJ; Gephart BD; Wang H; Vazquez-Perez J; Amanya SB; Hyslop ST; Yang J; Kemnade JO; Sandulache VC; Konduri V; Decker WK
FASEB J; 2024 May; 38(10):e23644. PubMed ID: 38738472
[TBL] [Abstract] [Full Text] [Related]
4. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.
Saldana-Guerrero IM; Montano-Gutierrez LF; Boswell K; Hafemeister C; Poon E; Shaw LE; Stavish D; Lea RA; Wernig-Zorc S; Bozsaky E; Fetahu IS; Zoescher P; Pötschger U; Bernkopf M; Wenninger-Weinzierl A; Sturtzel C; Souilhol C; Tarelli S; Shoeb MR; Bozatzi P; Rados M; Guarini M; Buri MC; Weninger W; Putz EM; Huang M; Ladenstein R; Andrews PW; Barbaric I; Cresswell GD; Bryant HE; Distel M; Chesler L; Taschner-Mandl S; Farlik M; Tsakiridis A; Halbritter F
Nat Commun; 2024 May; 15(1):3745. PubMed ID: 38702304
[TBL] [Abstract] [Full Text] [Related]
5. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract] [Full Text] [Related]
6. Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma.
Swellam M; Khalifa MK; Nageeb AM; Ezz El-Arab L; El-Mahdy M; El-Bahy K; Sayed Mahmoud M
Int J Immunopathol Pharmacol; 2024; 38():3946320241250294. PubMed ID: 38686946
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of the relationship between mycn gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract] [Full Text] [Related]
8. Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.
Banerjee D; Bagchi S; Liu Z; Chou HC; Xu M; Sun M; Aloisi S; Vaksman Z; Diskin SJ; Zimmerman M; Khan J; Gryder B; Thiele CJ
Nat Commun; 2024 Apr; 15(1):3432. PubMed ID: 38653778
[TBL] [Abstract] [Full Text] [Related]
9. Mitotic gene regulation by the n-myc-WDR5-PDPK1 nexus.
Streeter SA; Williams AG; Evans JR; Wang J; Guarnaccia AD; Florian AC; Al-Tobasei R; Liu Q; Tansey WP; Weissmiller AM
BMC Genomics; 2024 Apr; 25(1):360. PubMed ID: 38605297
[TBL] [Abstract] [Full Text] [Related]
10. Ependymomas of the spinal region in adults: Clinical and pathological features and mycn expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract] [Full Text] [Related]
11. SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Hua Z; Chen B; Gong B; Lin M; Ma Y; Li Z
CNS Neurosci Ther; 2024 Mar; 30(3):e14664. PubMed ID: 38516781
[TBL] [Abstract] [Full Text] [Related]
12. Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of mycn-amplified neuroblastoma.
Abu-Zaid A; Fang J; Jin H; Singh S; Pichavaram P; Wu Q; Tillman H; Janke L; Rosikiewicz W; Xu B; Van De Velde LA; Guo Y; Li Y; Shendy NAM; Delahunty IM; Rankovic Z; Chen T; Chen X; Freeman KW; Hatley ME; Durbin AD; Murray PJ; Murphy AJ; Thomas PG; Davidoff AM; Yang J
Cell Rep Med; 2024 Mar; 5(3):101468. PubMed ID: 38508144
[TBL] [Abstract] [Full Text] [Related]
13. CKLF instigates a "cold" microenvironment to promote mycn-mediated tumor aggressiveness.
Qin X; Lam A; Zhang X; Sengupta S; Iorgulescu JB; Ni H; Das S; Rager M; Zhou Z; Zuo T; Meara GK; Floru AE; Kemet C; Veerapaneni D; Kashy D; Lin L; Lloyd K; Kwok L; Smith KS; Nagaraju RT; Meijers R; Ceol C; Liu CT; Alexandrescu S; Wu CJ; Keskin DB; George RE; Feng H
Sci Adv; 2024 Mar; 10(11):eadh9547. PubMed ID: 38489372
[TBL] [Abstract] [Full Text] [Related]
14. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review.
Pi X; Zhang Q; Wang X; Jiang F
Mol Genet Genomic Med; 2024 Mar; 12(3):e2414. PubMed ID: 38465842
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
[TBL] [Abstract] [Full Text] [Related]
16. ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Huang M; Fang W; Farrel A; Li L; Chronopoulos A; Nasholm N; Cheng B; Zheng T; Yoda H; Barata MJ; Porras T; Miller ML; Zhen Q; Ghiglieri L; McHenry L; Wang L; Asgharzadeh S; Park J; Gustafson WC; Matthay KK; Maris JM; Weiss WA
Cell Rep; 2024 Mar; 43(3):113927. PubMed ID: 38451815
[TBL] [Abstract] [Full Text] [Related]
17. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
[TBL] [Abstract] [Full Text] [Related]
18. AF1q is a universal marker of neuroblastoma that sustains n-myc expression and drives tumorigenesis.
Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
[TBL] [Abstract] [Full Text] [Related]
19. mycn immunohistochemistry as surrogate marker for mycn-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract] [Full Text] [Related]
20. Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
Amano H; Uchida H; Harada K; Narita A; Fumino S; Yamada Y; Kumano S; Abe M; Ishigaki T; Sakairi M; Shirota C; Tainaka T; Sumida W; Yokota K; Makita S; Karakawa S; Mitani Y; Matsumoto S; Tomioka Y; Muramatsu H; Nishio N; Osawa T; Taguri M; Koh K; Tajiri T; Kato M; Matsumoto K; Takahashi Y; Hinoki A
Cancer Sci; 2024 May; 115(5):1634-1645. PubMed ID: 38411285
[TBL] [Abstract] [Full Text] [Related]
[Next]
